Glucose degradation products in peritoneal dialysis fluids: How they can be avoided

Peritoneal Dialysis International

Volumn 21, Issue SUPPL. 3, 2001, Pages

  Wieslander, Anders ^a   Linden, Torbjörn ^a   Kjellstrand, Per ^a  

^a Gambro AB   (Sweden)

Author keywords

Advanced glycation end products; Age; Biocompatibility; Cytotoxicity; GDP; Glucose degradation products; In vitro; Peritoneal dialysis fluids

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; LACTIC ACID; PERITONEAL DIALYSIS FLUID;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG MONITORING; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSMOLALITY; PERITONEAL DIALYSIS; PERITONEUM; PH; PRIORITY JOURNAL; STRESS;

EID: 0035568833     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080102103s21     Document Type: Article

References (31)

1. The effect of dialysate on peritoneal phagocyte oxidative metabolism
2. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bacterial activity in vitro
3. Leukotriene B4 and tumor necrosis factor release from leukocytes: Effect of peritoneal dialysate
4. In vitro formation of advanced glycation end-products in peritoneal dialysis fluid
5. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD
6. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function
7. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro
8. Toxicity of peritoneal dialysis fluids on cultured fibroblasts L-929
9. Effect of glucose degradation products on human peritoneal mesothelial cells
10. De l'action de la lumière et de l'air
11. The heat sterilization of fluids for peritoneal dialysis gives rise to several aldehydes
12. Role of glucose degradation products in the generation of characteristic AGE fluorescence in peritoneal dialysis fluid
13. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids
14. MEIC evaluation of acute systemic toxicity. Part VI. The prediction of human toxicity by rodent LD50 values and results from 61 in vitro methods
15. In vitro cytotoxicity of four different buffers for use in peritoneal dialysis
16. Exogenous uptake of carbonyl stress compounds promoting AGE formation from peritoneal dialysis
17. Heat sterilization of glucose-containing fluids for peritoneal dialysis; biological consequences of chemical alterations
18. Chemical peritonitis associated with high dialysate acetaldehyde concentrations
19. Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: Prospective cross-over study with a three-compartment bag
20. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products
21. Presence of GDP in PD fluids decreases ex vivo mesothelial cell regeneration
22. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain
23. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: A cytotoxicity test of CAPD solutions and effluents
24. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: Influence of time and temperature
25. Degradation in PD fluids may be avoided by low pH and high glucose concentration
26. Cytotoxicity, pH and glucose degradation products in four different brands of PD fluids
27. In vitro biocompatibility of a heat sterilized, low toxic and less acidic fluid for peritoneal dialysis
28. Cytotoxicity of glucose degradation in PD fluids
29. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis
30. Reduction of dicarbonyl compounds in a novel peritoneal dialysis solution
31. Reduced 1,2-dicarbonyl compounds in bicarbonate/lactate buffered peritoneal dialysis (PD) fluids and PD fluids based on glucose polymers or amino acids